These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 25228949)

  • 1. Pulmonary hypertension and metabolic syndrome: Possible connection, PPARγ and Caveolin-1.
    Mathew R
    World J Cardiol; 2014 Aug; 6(8):692-705. PubMed ID: 25228949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peroxisome Proliferator-Activated Receptor γ-Mediated Inhibition on Hypoxia-Triggered Store-Operated Calcium Entry. A Caveolin-1-Dependent Mechanism.
    Yang K; Lu W; Jiang Q; Yun X; Zhao M; Jiang H; Wang J
    Am J Respir Cell Mol Biol; 2015 Dec; 53(6):882-92. PubMed ID: 26020612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Review: Peroxisome proliferator-activated receptor gamma and adipose tissue--understanding obesity-related changes in regulation of lipid and glucose metabolism.
    Sharma AM; Staels B
    J Clin Endocrinol Metab; 2007 Feb; 92(2):386-95. PubMed ID: 17148564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological activation of PPARγ inhibits hypoxia-induced proliferation through a caveolin-1-targeted and -dependent mechanism in PASMCs.
    Yang K; Zhao M; Huang J; Zhang C; Zheng Q; Chen Y; Jiang H; Lu W; Wang J
    Am J Physiol Cell Physiol; 2018 Apr; 314(4):C428-C438. PubMed ID: 29351409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adipokines and Metabolic Regulators in Human and Experimental Pulmonary Arterial Hypertension.
    Papathanasiou AE; Spyropoulos F; Michael Z; Joung KE; Briana DD; Malamitsi-Puchner A; Mantzoros CS; Christou H
    Int J Mol Sci; 2021 Feb; 22(3):. PubMed ID: 33535425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is peroxisome proliferator-activated receptor gamma (PPARγ) a therapeutic target for the treatment of pulmonary hypertension?
    Green DE; Sutliff RL; Hart CM
    Pulm Circ; 2011 Jan; 1(1):33-47. PubMed ID: 21547012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The role of peroxisome proliferator-activated receptors γ (PPARγ) in obesity and insulin resistance].
    Chmielewska-Kassassir M; Woźniak LA; Ogrodniczek P; Wójcik M
    Postepy Hig Med Dosw (Online); 2013 Dec; 67():1283-99. PubMed ID: 24379269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Redox Biology of Peroxisome Proliferator-Activated Receptor-γ in Pulmonary Hypertension.
    Tseng V; Sutliff RL; Hart CM
    Antioxid Redox Signal; 2019 Oct; 31(12):874-897. PubMed ID: 30582337
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of PPARgamma inhibition on pulmonary endothelial cell gene expression: gene profiling in pulmonary hypertension.
    Tian J; Smith A; Nechtman J; Podolsky R; Aggarwal S; Snead C; Kumar S; Elgaish M; Oishi P; Göerlach A; Fratz S; Hess J; Catravas JD; Verin AD; Fineman JR; She JX; Black SM
    Physiol Genomics; 2009 Dec; 40(1):48-60. PubMed ID: 19825830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New approach in the treatment of T2DM and metabolic syndrome (focus on a novel insulin sensitizer).
    Tjokroprawiro A
    Acta Med Indones; 2006; 38(3):160-6. PubMed ID: 17119268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced caveolin-1 expression in smooth muscle cells: Possible prelude to neointima formation.
    Huang J; Wolk JH; Gewitz MH; Loyd JE; West J; Austin ED; Mathew R
    World J Cardiol; 2015 Oct; 7(10):671-84. PubMed ID: 26516422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adiponectin and PPARγ: cooperative and interdependent actions of two key regulators of metabolism.
    Astapova O; Leff T
    Vitam Horm; 2012; 90():143-62. PubMed ID: 23017715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel approach to treat insulin resistance, type 2 diabetes, and the metabolic syndrome: simultaneous activation of PPARalpha, PPARgamma, and PPARdelta.
    Evans JL; Lin JJ; Goldfine ID
    Curr Diabetes Rev; 2005 Aug; 1(3):299-307. PubMed ID: 18220606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PPARgamma as a potential therapeutic target in pulmonary hypertension.
    Sutliff RL; Kang BY; Hart CM
    Ther Adv Respir Dis; 2010 Jun; 4(3):143-60. PubMed ID: 20530063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic potential of the dual peroxisome proliferator activated receptor (PPAR)α/γ agonist aleglitazar in attenuating TNF-α-mediated inflammation and insulin resistance in human adipocytes.
    Massaro M; Scoditti E; Pellegrino M; Carluccio MA; Calabriso N; Wabitsch M; Storelli C; Wright M; De Caterina R
    Pharmacol Res; 2016 May; 107():125-136. PubMed ID: 26976796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term angiotensin II AT1 receptor inhibition produces adipose tissue hypotrophy accompanied by increased expression of adiponectin and PPARgamma.
    Zorad S; Dou JT; Benicky J; Hutanu D; Tybitanclova K; Zhou J; Saavedra JM
    Eur J Pharmacol; 2006 Dec; 552(1-3):112-22. PubMed ID: 17064684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peroxisome Proliferator-Activated Receptor γ Agonist Rosiglitazone Protects Blood-Brain Barrier Integrity Following Diffuse Axonal Injury by Decreasing the Levels of Inflammatory Mediators Through a Caveolin-1-Dependent Pathway.
    Zhao Y; Wei X; Song J; Zhang M; Huang T; Qin J
    Inflammation; 2019 Jun; 42(3):841-856. PubMed ID: 30488141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dietary regulation of nuclear receptors in obesity-related metabolic syndrome.
    Kawada T; Goto T; Hirai S; Kang MS; Uemura T; Yu R; Takahashi N
    Asia Pac J Clin Nutr; 2008; 17 Suppl 1():126-30. PubMed ID: 18296319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypoxia downregulates PPARγ via an ERK1/2-NF-κB-Nox4-dependent mechanism in human pulmonary artery smooth muscle cells.
    Lu X; Bijli KM; Ramirez A; Murphy TC; Kleinhenz J; Hart CM
    Free Radic Biol Med; 2013 Oct; 63():151-60. PubMed ID: 23684777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathogenesis of pulmonary hypertension: a case for caveolin-1 and cell membrane integrity.
    Mathew R
    Am J Physiol Heart Circ Physiol; 2014 Jan; 306(1):H15-25. PubMed ID: 24163076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.